Riken Vitamin Co., Ltd. provided earnings guidance for the six months ending September 30, 2023 and full year ending March 31, 2024. For the Six months ending September 30, 2023, the company expects set sales of JPY 45,500 million, operating profit of JPY 3,200 million, profit attributable to owners of parent of JPY 2,600 million and earnings per share of JPY 79.23.

For the year, the company expects set sales of JPY 92,000 million, operating profit of JPY 6,800 million, profit attributable to owners of parent of JPY 5,600 million and earnings per share of JPY 170.64.